Remotely Delivered Behavioral Intervention Reduces Systolic BP Variation
By Elana Gotkine HealthDay Reporter
Medically reviewed by Drugs.com

THURSDAY, Aug. 21, 2025 -- A remotely delivered behavioral intervention can reduce variability in systolic blood pressure, expressed as the coefficient of variation (BPCoV), according to a study published online Aug. 12 in Scientific Reports.
Eyal Shemesh, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues conducted a single-arm prospective proof-of-concept trial involving patients with excessive variability in systolic blood pressure (BPCoV >10 percent) identified from a review of electronic health records. Participants received a blood pressure monitor and a remotely delivered behavioral intervention for three months.
Overall, 107 of the 551 initially screened patients met the BPCoV criteria, and 25 consented. The researchers found that for the six-month period before enrollment, the average BPCoV was 12.96 compared with 7.02 during the intervention. Improvement was also observed in other variability metrics. Significant improvement was seen in sensitivity analyses (different timeframes, using measurements obtained in the clinic versus home monitor).
"Doctors should not only focus on patients' blood pressure at a specific visit but also look at what happens with the patient over time, to identify instances where measurements vary a lot between visits," Shemesh said in a statement. "This trial showed that patients can be engaged remotely in an intervention aiming to stabilize their blood pressure readings."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-22 06:00
Read more

- Long-Term Exposure to Air Pollution Tied to Higher Risk for Dementia
- Physicians Exiting Traditional Medicare Accelerated From 2010 to 2023
- Endurance Athletes Could Be At Increased Risk Of Dangerous Heart Scarring, Researchers Say
- Bans on Flavored Vapes Have Pros And Cons, Study Finds
- Less Processed Diet May Be More Beneficial for Weight Loss
- Sending Unsolicited Stool Test Kits The Best Way To Boost Colon Cancer Screening, Study Argues
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions